Page last updated: 2024-08-21

durapatite and HIV-Associated Lipodystrophy Syndrome

durapatite has been researched along with HIV-Associated Lipodystrophy Syndrome in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (64.29)	29.6817
2010's	4 (28.57)	24.3611
2020's	1 (7.14)	2.80

Authors

Authors	Studies
Burgess, C; Williams, MN	1
Amore, R; Colella, G; Curinga, G; Rauso, R; Rusciani, A; Tartaro, G	1
Duyndam, DA; Kadouch, JA; Karim, RB; Lutgendorff, F; Nieuwkerk, PT; van Rozelaar, L	1
Chapman, LW; Korta, DZ; Kraus, CN; Zachary, CB	1
Carruthers, A; Carruthers, J; Forster, BB; Liebeskind, M	1
Sadick, NS	1
Hilton, S	1
Lizzul, PF; Narurkar, VA	1
Echavez, MI; Eviatar, JA; Pappas, AL; Silvers, SL	1
Cieszynski, SA; Comite, S; Greene, A; Marks, K; Zaroovabeli, P	1
Môle, B	1
Beer, K; Cohen, JL; Yohn, M	1
Jacovella, PF	1

Reviews

4 review(s) available for durapatite and HIV-Associated Lipodystrophy Syndrome

Article	Year
Quality of life outcomes associated with treatment of human immunodeficiency virus (HIV) facial lipoatrophy. International journal of dermatology, 2016, Volume: 55, Issue:12 Topics: Acrylic Resins; Adipose Tissue; Dermal Fillers; Durapatite; Face; HIV-Associated Lipodystrophy Syndrome; Humans; Hyaluronic Acid; Polyesters; Polymethyl Methacrylate; Quality of Life; Silicone Oils	2016
The impact of cosmetic interventions on quality of life. Dermatology online journal, 2008, Aug-15, Volume: 14, Issue:8 Topics: Acrylic Resins; Biocompatible Materials; Botulinum Toxins, Type A; Clinical Trials as Topic; Cosmetic Techniques; Cosmetics; Durapatite; Facial Dermatoses; HIV-Associated Lipodystrophy Syndrome; Humans; Hyaluronic Acid; Injections; Lactic Acid; Plastic Surgery Procedures; Polyesters; Polymers; Quality of Life; United States	2008
The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation. Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:5 Topics: Biocompatible Materials; Cosmetic Techniques; Durapatite; Face; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Intradermal; Rejuvenation; Skin Aging; United States	2010
Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clinical interventions in aging, 2008, Volume: 3, Issue:1 Topics: Biocompatible Materials; Cheek; Durapatite; Face; HIV-Associated Lipodystrophy Syndrome; Humans; Nerve Block; Plastic Surgery Procedures; Prostheses and Implants	2008

Trials

1 trial(s) available for durapatite and HIV-Associated Lipodystrophy Syndrome

Article	Year
Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plastic and reconstructive surgery, 2006, Volume: 118, Issue:3 Suppl Topics: Adult; Anthropometry; Biocompatible Materials; Cheek; Cosmetic Techniques; Durapatite; Ecchymosis; Esthetics; Female; Follow-Up Studies; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Subcutaneous; Male; Microspheres; Middle Aged; Patient Satisfaction; Prospective Studies; Severity of Illness Index; Treatment Outcome	2006

Article

Year

Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.

Plastic and reconstructive surgery, 2006, Volume: 118, Issue:3 Suppl

Topics: Adult; Anthropometry; Biocompatible Materials; Cheek; Cosmetic Techniques; Durapatite; Ecchymosis; Esthetics; Female; Follow-Up Studies; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Subcutaneous; Male; Microspheres; Middle Aged; Patient Satisfaction; Prospective Studies; Severity of Illness Index; Treatment Outcome

2006

Other Studies

9 other study(ies) available for durapatite and HIV-Associated Lipodystrophy Syndrome

Article	Year
Management of Calcium Hydroxyapatite Vascular Occlusion in a Hemophiliac With HIV-Associated Facial Lipoatrophy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 08-01, Volume: 47, Issue:8 Topics: Administration, Cutaneous; Combined Modality Therapy; Dermal Fillers; Durapatite; Face; Facial Dermatoses; Hemophilia A; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Nitroglycerin; Phototherapy; Skin Diseases, Vascular; Treatment Outcome	2021
Safety and efficacy of one-step rehabilitation of human immunodeficiency virus-related facial lipoatrophy using an injectable calcium hydroxylapatite dermal filler. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:12 Topics: Adult; Biocompatible Materials; Cosmetic Techniques; Durapatite; Face; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Injections; Male; Middle Aged; Prospective Studies; Treatment Outcome	2013
Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life. Aesthetic surgery journal, 2014, Jan-01, Volume: 34, Issue:1 Topics: Adult; Aged; Biocompatible Materials; Cosmetic Techniques; Durapatite; Face; Female; HIV Seropositivity; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Subcutaneous; Lactic Acid; Magnetic Resonance Imaging; Male; Middle Aged; Polyesters; Polymers; Predictive Value of Tests; Prospective Studies; Quality of Life; Subcutaneous Fat; Surveys and Questionnaires; Time Factors; Treatment Outcome	2014
Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34 Suppl 1 Topics: Adult; Aged, 80 and over; Anthropometry; Biocompatible Materials; Cosmetic Techniques; Durapatite; Face; Female; Follow-Up Studies; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Subcutaneous; Male; Microspheres; Middle Aged; Single-Blind Method; Skin Aging; Tomography, X-Ray Computed; X-Rays	2008
[Treatment of facial lipatrophy]. MMW Fortschritte der Medizin, 2009, Apr-30, Volume: 151, Issue:18 Topics: Adipose Tissue; Antiretroviral Therapy, Highly Active; Biocompatible Materials; Cheek; Durapatite; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hyaluronic Acid; Injections; Lactic Acid; Plastic Surgery Procedures; Polyesters; Polymers; Viscosupplements	2009
HIV approval for wrinkle filler. AIDS patient care and STDs, 2007, Volume: 21, Issue:2 Topics: Cosmetic Techniques; Drug Approval; Durapatite; HIV-Associated Lipodystrophy Syndrome; Humans; United States; United States Food and Drug Administration	2007
Minimizing discomfort during the injection of Radiesse with the use of either local anesthetic or ice. Dermatology online journal, 2007, Jul-13, Volume: 13, Issue:3 Topics: Anesthesia, Local; Anesthetics, Local; Biocompatible Materials; Durapatite; HIV-Associated Lipodystrophy Syndrome; Humans; Hypothermia, Induced; Ice; Injections; Lip; Nose; Pain; Pain Measurement; Patient Satisfaction; Skin Aging; Treatment Outcome	2007
[Long-lasting filling procedures]. Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:1 Pt 2 Topics: Acrylates; Acrylic Resins; Biocompatible Materials; Cellulose; Cosmetic Techniques; Durapatite; HIV-Associated Lipodystrophy Syndrome; Humans; Hyaluronic Acid; Hydrogels; Injections, Intradermal; Lactic Acid; Mannitol; Microspheres; Polymethyl Methacrylate; Polytetrafluoroethylene; Rejuvenation; Silicone Oils; Skin Aging	2008
Evaluation of injectable CaHA for the treatment of mid-face volume loss. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:4 Topics: Adult; Aged; Body Mass Index; Cheek; Cosmetic Techniques; Durapatite; Female; Gels; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Intradermal; Middle Aged; Patient Satisfaction; Pilot Projects; Rejuvenation	2008